Research Partnerships

Great science means sharing knowledge and resources to work faster and achieve more.

 

Academic collaborations are a rich source of creativity and scientific talent. Pooling resources and expertise can help the UK life sciences community to find and develop new medicines and vaccines. It’s what we call our “R&D ecosystem”.

Pfizer contributes to over a hundred research collaborations and strategic alliances across the UK.1 Through these partnerships, we work with scientists, academics and clinicians to deliver world leading scientific research.

 

Innovative Target Exploration Network (ITEN)

Our Science
Innovative Target Exploration Network
Innovative Target Exploration Network
Innovative Target Exploration Network
Innovative Target Exploration Network

Innovative Target Exploration Network (ITEN)

An early-stage partnering model that fosters collaborative relationships with selected academic institutions in key hubs of scientific excellence.

Partnership with Regeneron for UK Biobank exome sequencing

Our Science
Partnership with Regeneron
Partnership with Regeneron
Partnership with Regeneron
Partnership with Regeneron
Partnership with Regeneron

Partnership with Regeneron for UK Biobank exome sequencing

We are part of a collaboration that aims to speed up the exome sequencing of 500,000 UK participants.

The Stratified Medicine Programme

Our Science
Stratified Medicine Programme
Stratified Medicine Programme
Stratified Medicine Programme
Stratified Medicine Programme

The Stratified Medicine Programme

A collaborative initiative that aims to make a difference to patients with cancer through ‘precision’ medicine.

INSPIRE Programme

Our Science
INSPIRE Programme
INSPIRE Programme
INSPIRE Programme
INSPIRE Programme

INSPIRE Programme

Our INSPIRE partnerships with NHS research networks are part of Pfizer’s international network of preferred sites for clinical research.

ADDoPT

Our Science
ADDoPT
ADDoPT
ADDoPT
ADDoPT

ADDoPT

In 2015 we joined ADDoPT, a 4 year £20.4 million collaborative project between government, pharmaceutical companies, SME's and academia.

Medical Research Council Collaboration

Our Science
Medical Research Council Collaboration
Medical Research Council Collaboration
Medical Research Council Collaboration
Medical Research Council Collaboration

Medical Research Council Collaboration

Between 2014 and 2018, Pfizer collaborated with the UK-based Medical Research Council to make available a ‘virtual library’ of compounds for use by academic researchers in the UK.

References

  1. Pfizer data on file. March 2021.

 

PP-PFE-GBR-4098 / November 2021